FY 2025
Loading financial data...
|
Chart |
FY21
Dec 31, 2021
|
FY22
Dec 31, 2022
|
FY23
Dec 31, 2023
|
FY24
Dec 31, 2024
|
FY25
Dec 31, 2025
|
TTM
Trailing 12M
|
|---|---|---|---|---|---|---|---|
|
Revenue
Total sales generated. |
|
$11.89 B | $12.68 B | $14.24 B | $16.75 B | $20.07 B | $20.62 B |
|
Cost of Revenue Direct cost of goods/services. |
|
$4.43 B | $4.97 B | $5.41 B | $6.48 B | $6.22 B | $6.10 B |
Gross Profit Revenue minus cost of revenue. |
|
$7.46 B | $7.71 B | $8.83 B | $10.27 B | $13.85 B | $14.52 B |
|
Operating Expense
Costs to run business. 
|
|
$5.54 B | $5.89 B | $6.65 B | $7.63 B | $9.88 B | $10.37 B |
Operating Income Profit from operations. |
|
$1.92 B | $1.82 B | $2.18 B | $2.64 B | $3.97 B | $4.15 B |
|
Net Interest Income
Interest income minus expense.
|
|
-$345.00 M | -$454.00 M | -$250.00 M | -$280.00 M | -$349.00 M | -$357.00 M |
Non-Operating Income (ex-Int) Income outside core operations. |
|
$497.00 M | $219.00 M | -$76.00 M | -$34.00 M | $238.00 M | $62.00 M |
Total Other Income (Net) Net non-operating items. |
|
-$846.00 M | -$683.00 M | -$196.00 M | -$353.00 M | -$586.00 M | -$405.00 M |
Income Before Tax Profit before taxes. |
|
$1.08 B | $1.14 B | $1.99 B | $2.28 B | $3.39 B | $3.74 B |
Income Tax Expense Taxes on income. |
|
$36.00 M | $443.00 M | $393.00 M | $436.00 M | $493.00 M | $184.00 M |
|
Net Income
Final profit.
|
|
$1.04 B | $698.00 M | $1.59 B | $1.85 B | $2.89 B | $3.55 B |
|
Earnings Per Share
Company profit allocated to each outstanding share. |
|||||||
EPS Earnings per share. Formula: Net Income ÷ Shares |
|
$0.69 | $0.45 | $1.08 | $1.26 | $1.96 | $2.40 |
Diluted EPS EPS including dilution. Formula: Net Income ÷ Diluted Shares |
|
$0.69 | $0.45 | $1.07 | $1.25 | $1.94 | $2.38 |
|
Shares for EPS
Number of shares used to calculate EPS. |
|||||||
Weighted Average Shares Outst. Avg shares used for EPS. |
|
1.42 B | 1.43 B | 1.45 B | 1.47 B | 1.48 B | 1.48 B |
Diluted Average Shares Outst. Shares including dilution. |
|
1.43 B | 1.44 B | 1.46 B | 1.49 B | 1.49 B | 1.50 B |
| Supplemental Items | |||||||
EBIT Earnings before interest and tax. |
|
$1.43 B | $1.61 B | $2.26 B | $2.67 B | $3.73 B | $4.09 B |
EBITDA Earnings before interest, tax, D&A. |
|
$2.52 B | $2.74 B | $3.45 B | $3.94 B | $3.73 B | $4.76 B |
Depreciation and Amortization Non-cash expense for assets. |
|
$1.09 B | $1.14 B | $1.20 B | $1.27 B | - | $678.00 M |
| Company Report |
FY 2025
Boston Scientific Corporation's Balance Sheet
-
$ USD
-
€ EUR
-
€ EUR
-
€ EUR
-
-
-
| Loading balance sheet when needed... |
Boston Scientific Corporation's Cash flow
-
$ USD
-
€ EUR
-
€ EUR
-
€ EUR
-
-
-
| Loading cash flow statement when needed... |
Boston Scientific Corporation's Profitability
-
$ USD
-
€ EUR
-
€ EUR
-
€ EUR
-
-
-
| Loading profitability metrics when needed... |
Boston Scientific Corporation's Ratios
-
$ USD
-
€ EUR
-
€ EUR
-
€ EUR
-
-
-
